Witnessing the stock’s movement on the chart, on Wednesday, Alzamend Neuro Inc (NASDAQ: ALZN) had a quiet start as it plunged -6.48% to $1.01, before settling in for the price of $1.08 at the close. Taking a more long-term approach, ALZN posted a 52-week range of $1.05-$15.06.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 0.00%. Meanwhile, its Annual Earning per share during the time was -11.45%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 88.57%. This publicly-traded company’s shares outstanding now amounts to $5.23 million, simultaneously with a float of $5.23 million. The organization now has a market capitalization sitting at $5.49 million. At the time of writing, stock’s 50-day Moving Average stood at $1.1670, while the 200-day Moving Average is $2.6645.
Alzamend Neuro Inc (ALZN) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Alzamend Neuro Inc’s current insider ownership accounts for 3.75%, in contrast to 2.09% institutional ownership. According to the most recent insider trade that took place on Aug 06 ’24, this organization’s Director bought 75 shares at the rate of 2.75, making the entire transaction reach 206 in total value, affecting insider ownership by 77,268. Preceding that transaction, on Jul 31 ’24, Company’s Director bought 25 for 3.74, making the whole transaction’s value amount to 93. This particular insider is now the holder of 77,193 in total.
Alzamend Neuro Inc (ALZN) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.45 per share during the current fiscal year.
Alzamend Neuro Inc’s EPS increase for this current 12-month fiscal period is 88.57% and is forecasted to reach -1.71 in the upcoming year.
Alzamend Neuro Inc (NASDAQ: ALZN) Trading Performance Indicators
Let’s observe the current performance indicators for Alzamend Neuro Inc (ALZN). It’s Quick Ratio in the last reported quarter now stands at 3.80. The Stock has managed to achieve an average true range (ATR) of 0.07.
In the same vein, ALZN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -6.65, a figure that is expected to reach -0.29 in the next quarter, and analysts are predicting that it will be -1.71 at the market close of one year from today.
Technical Analysis of Alzamend Neuro Inc (ALZN)
Going through the that latest performance of [Alzamend Neuro Inc, ALZN]. Its last 5-days volume of 2.94 million indicated improvement to the volume of 0.53 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 27.57% While, its Average True Range was 0.0718.
Raw Stochastic average of Alzamend Neuro Inc (ALZN) in the period of the previous 100 days is set at 9.11%, which indicates a major fall in contrast to 33.14% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 41.59% that was lower than 55.55% volatility it exhibited in the past 100-days period.
